低剂量阿司匹林预防股骨颈骨折术后静脉血栓栓塞安全有效
基于国家数据库36,576例因股骨颈骨折行关节置换术的患者,比较低剂量阿司匹林(81 mg)与非阿司匹林预防对90天内静脉血栓栓塞及不良事件的影响,倾向性匹配后显示低剂量阿司匹林与深静脉血栓和肺栓塞 odds 降低相关,且出血、输血和急诊就诊 odds 更低。
要点
- 高危组中低剂量阿司匹林较非阿司匹林预防深静脉血栓 OR 0.46(95%CI 0.30-0.69),肺栓塞 OR 0.27(95%CI 0.14-0.55)。
- 标准风险组中低剂量阿司匹林深静脉血栓 OR 0.37(95%CI 0.18-0.76),肺栓塞 OR 0.71(95%CI 0.32-1.61)无显著差异。
- 低剂量阿司匹林与出血事件、输血需求和急诊就诊 odds 降低相关。
核心结论
- 使用低剂量阿司匹林预防股骨颈骨折关节置换术后静脉血栓栓塞是安全有效的。
- 因该人群死亡风险较高,需要前瞻性研究比较静脉血栓栓塞预防方案以进一步改善临床结局。
研究设计与样本
- 从2012年1月至2023年12月国家数据库识别36,576例因股骨颈骨折行关节置换术的患者。
- 按基线静脉血栓栓塞风险分为高危组和标准风险组,再按预防类型分为仅低剂量阿司匹林组和仅非阿司匹林预防组。
- 采用倾向性匹配队列评估术后90天内深静脉血栓、肺栓塞及不良事件(出血、输血需求、急诊就诊)的发生率和 odds。
主要发现
- 高危组中低剂量阿司匹林较非阿司匹林预防深静脉血栓 OR 0.46(95%CI 0.30-0.69),肺栓塞 OR 0.27(95%CI 0.14-0.55)。
- 标准风险组中低剂量阿司匹林较非阿司匹林预防深静脉血栓 OR 0.37(95%CI 0.18-0.76),肺栓塞 OR 0.71(95%CI 0.32-1.61)无显著差异。
- 低剂量阿司匹林与出血事件、输血需求和急诊就诊的 odds 降低相关。
关键数值与推荐
- 低剂量阿司匹林为81 mg。
- 高危组深静脉血栓 OR 0.46(95%CI 0.30-0.69),肺栓塞 OR 0.27(95%CI 0.14-0.55)。
- 标准风险组深静脉血栓 OR 0.37(95%CI 0.18-0.76),肺栓塞 OR 0.71(95%CI 0.32-1.61)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although patients who undergo arthroplasty for hip fractures are at high risk of venous thromboembolism (VTE), current guidelines do not specify the optimal VTE prophylactic agent. Recent evidence demonstrates that aspirin (ASA) may be safe and effective for VTE prevention in these patients. The purpose of this study was to determine the safety and efficacy of low-dose ASA (81 mg) compared to non-ASA agents after arthroplasty for femoral neck fracture. METHODS: A total of 36,576 patients who underwent arthroplasty for femoral neck fracture from January 2012 through December 2023 were identified in a national database. Patients were stratified by baseline VTE risk into high-risk and standard-risk groups and further categorized based on the type of VTE prophylaxis received - low-dose ASA only or non-ASA prophylaxis only. Rates and odds of deep vein thrombosis, pulmonary embolism (PE), and adverse events, including bleeding, blood transfusion requirements, and emergency department visits, were assessed in the 90-days postoperative period for propensity-matched cohorts. RESULTS: Compared to non-ASA prophylaxis, use of low-dose ASA only was associated with significantly lower odds of deep vein thrombosis in both high-risk (odds ratio [OR]: 0.46; 95% confidence interval [CI]: 0.30 to 0.69) and standard-risk (OR: 0.37; 95% CI: 0.18 to 0.76) groups, and lower odds of PE in high-risk patients (OR: 0.27; 95% CI: 0.14 to 0.55). There were no significant differences in odds of PE in standard-risk patients (OR: 0.71; 95% CI: 0.32 to 1.61). Low-dose ASA was associated with lower odds of bleeding events, blood transfusion requirements, and emergency department visits. CONCLUSIONS: Use of low-dose ASA is safe and effective in preventing VTE in patients undergoing arthroplasty for femoral neck fracture. As this population is at higher risk of mortality, prospective studies comparing VTE prophylaxis regimens are necessary to further improve clinical outcomes. LEVEL OF EVIDENCE: III.
引用
- Zhao AY, Gu A, Shah A, et al. Low-Dose Aspirin Is Safe and Effective for Prevention of Venous Thromboembolism After Femoral Neck Fracture. J Arthroplasty. 2025. PMID: 40132697. doi:10.1016/j.arth.2025.03.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。